Kazuya Sakai Selected Research

Kazuya Sakai Research Topics

Disease

16	Thrombotic Thrombocytopenic Purpura 02/2024 - 01/2020
8	COVID-19 12/2023 - 01/2020
3	Thrombocytopenia (Thrombopenia) 11/2023 - 05/2018
3	Disseminated Intravascular Coagulation 02/2023 - 04/2021
3	Thrombosis (Thrombus) 11/2022 - 07/2019
3	Neoplasms (Cancer) 12/2021 - 09/2017
2	Thrombotic Microangiopathies 09/2023 - 01/2021
2	Rare Diseases (Rare Disease) 05/2023 - 10/2019
2	Essential Thrombocythemia 01/2022 - 08/2018
2	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2018
2	acquired Thrombotic thrombocytopenic purpura 04/2021 - 11/2020
2	Pneumonia (Pneumonitis) 01/2021 - 08/2020
1	Body Weight (Weight, Body) 01/2024
1	Hemolytic Anemia 11/2023
1	Hypersensitivity (Allergy) 01/2023
1	Ischemic Stroke 11/2022
1	Stroke (Strokes) 11/2022
1	Evans Syndrome 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Broca Aphasia (Expressive Aphasia) 01/2022
1	Infertility (Sterility) 12/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2021
1	Left Ventricular Dysfunction 10/2021
1	Myocarditis (Carditis) 10/2021
1	Ventricular Remodeling 10/2021
1	Sudden Death 10/2021
1	Bradycardia 10/2021
1	Hypotension (Low Blood Pressure) 10/2021
1	Hypernatremia 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Disease Progression 08/2020
1	Hemolysis 01/2020
1	Infections 01/2020
1	Fatigue 01/2020
1	Muscular Atrophy (Muscle Atrophy) 11/2019

Drug/Important Bio-Agent (IBA)

9	von Willebrand FactorIBA 02/2024 - 09/2017
8	thiamine triphosphorate (TTP)IBA 11/2023 - 10/2019
6	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2018
5	AutoantibodiesIBA 10/2023 - 01/2020
4	Metalloproteases (Metalloproteinases)IBA 09/2023 - 09/2017
3	ThrombospondinsIBA 09/2023 - 09/2017
3	Dacarbazine (DIC)FDA LinkGeneric 02/2023 - 04/2021
2	caplacizumabIBA 02/2024 - 11/2020
2	Blood Glucose (Blood Sugar)IBA 12/2023 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2023 - 01/2021
2	DisintegrinsIBA 09/2023 - 05/2023
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2022 - 05/2018
2	Rituximab (Mabthera)FDA Link 08/2022 - 12/2020
2	SteroidsIBA 01/2022 - 05/2018
2	AntigensIBA 07/2019 - 09/2017
1	Soybean Proteins (Soy Protein)IBA 01/2024
1	Factor XIII (Coagulation Factor XIII)IBA 02/2023
1	HaptoglobinsIBA 02/2023
1	Peptides (Polypeptides)IBA 01/2023
1	GlucocorticoidsIBA 08/2022
1	ADAMTS13 ProteinIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	EnzymesIBA 01/2022
1	VaccinesIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	CollagenIBA 10/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	Blood Proteins (Serum Proteins)IBA 10/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Syndecan-1 (Syndecan 1)IBA 08/2021
1	formycin diphosphate (FDP)IBA 04/2021
1	Cholinesterases (Cholinesterase)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SodiumIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	botrocetinIBA 11/2020
1	RistocetinIBA 11/2020
1	ARC 1779IBA 11/2020
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Platelet Membrane GlycoproteinsIBA 11/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2020
1	DiamondIBA 08/2020
1	C-Reactive ProteinIBA 08/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2020
1	Serum AlbuminIBA 08/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2020
1	ravulizumabIBA 01/2020
1	ciclesonide FDA Link 01/2020
1	eculizumab FDA Link 01/2020
1	Polymethyl Methacrylate (Sol)IBA 11/2019

Therapy/Procedure

3	Therapeutics 05/2023 - 01/2021
3	Plasma Exchange 01/2023 - 10/2021
3	Drug Therapy (Chemotherapy) 12/2021 - 04/2011
1	Thrombectomy 11/2022
1	Aftercare (After-Treatment) 08/2022
1	Salvage Therapy 08/2022
1	Plasmapheresis 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2022
1	Critical Care (Surgical Intensive Care) 08/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Off-Label Use 12/2020
1	Personal Protective Equipment 01/2020